Other headlines:Barco recruits hospital showcaseNightHawk names new CMO
Attendance was down about 5% at this year's HIMSS conference held April 4 to 8 in Chicago. The meeting, which focuses on healthcare information technology, still drew a respectable 27,500 attendees, however. Its sponsor, the Healthcare Information and Management Systems Society, credited President Obama's call for computerized health records for all U.S. patients by 2014 and Chicago's central location for the strong showing.
On April 28, Barco and the Dienst Medische Beeldvorming (Medical Imaging Department) of the AZ Groeninge hospital in Kortrijk, Belgium, plan to sign a Reference Site Program Agreement, providing the Belgian company with an internationally known hospital facility close to its headquarters to showcase product developments.
Effective April 14, Dr. Timothy V. Myers has joined NightHawk Radiology as chief medical officer and senior vice president. For the past eight years, Myers has served as a practicing radiologist and head of the teleradiology division at St. Paul Radiology, one of the largest radiology groups in the country. He will receive an annual base salary of $400,000 and annual performance-based incentives up to 80% of this base. He has also been granted a restricted stock unit of 40,000 shares and an option to purchase up to 40,000 shares of NightHawk stock.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.